Company Data

Exagen Inc.

Ticker
XGN
Current Price
$3.58 -5.29%
Market Cap
$63.1M
Price Target
Refer to Report
Volume
54.3K
52wk Range
$1.3003 - $6.22
Advanced Market Data

Overview

Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy